| Tag | Content |
|---|
EnhancerAtlas ID | HS177-18587 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH_RA |
Coordinate | chr5:142357070-142357880 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Myod1 | MA0499.1 | chr5:142357212-142357225 | AGCAGCTGTCTCT | + | 6.32 | | NFAT5 | MA0606.1 | chr5:142357619-142357629 | ATTTTCCATT | + | 6.02 | | NFATC1 | MA0624.1 | chr5:142357619-142357629 | ATTTTCCATT | + | 6.02 | | NFATC3 | MA0625.1 | chr5:142357619-142357629 | ATTTTCCATT | + | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09220 | chr5:142352975-142359932 | CD14 | | SE_20025 | chr5:142348657-142359928 | CD56 | | SE_22391 | chr5:142348639-142359898 | CD8_primiary |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I142976 | chr5 | 142355818 | 142359764 |
|
Enhancer Sequence | GTCCTGGGGC TGCCACAGGT CAGCCAGGTG TTTTTTTCCC CCTGCTGGAT ACGGATCTTT 60
GGACATTTGC CTCCAGTCTT TGCGTTGAAC TCAGCAGTTT CCTGGGTGAG GAGGCAACCT 120
TTGTGTGCTC AGCTTCTTCC AAAGCAGCTG TCTCTAGAAG TTGCTAGCCA TCTCCTGGTT 180
AAGAAAGAAG ATGGAAGGTG GTAGGGAGAG GAAGCAAAAA CATTTCACAC TGCCTCCCCA 240
AAGACAGATC TGTTATCCTG CCTTGACCAC AAAAATTCAC GGAGGAAGTC AGTGAGTCAG 300
AGATGCGCCA GGGTGTAAGT TGTCAGCACA GTTCAGCGAG CTCTGGTATC TTGTGTTTCT 360
CTGTTCGTAC CACTACTGCT TTCCTTCCTG GCTACATTCA CCAGCATGAA GAAACTGGAG 420
CAGCACCTTG AGAGGTTTCA TCAGCCCATG GCTGGGATGG TTGACAGATC ACTTGCAAAG 480
CCATGGGAAA AGGACCTGGT TCCTCTTGAC TCCTCTGACT TATTTTCAGT GATCCGACAT 540
CTTGAAAATA TTTTCCATTT CACTCCTAGG TTCTTGTAGG CCTTCCCACA ATGAGCACAT 600
TCAGTCTTAA AAATTTTTTT TCTGCTTTAA TTGGCGTGGG GTCGGATCGC TTCTCCTTGG 660
GTCTTAACTG TATTCAGAGG GGCTTAGGGT TTGCCCAAGG CCTCAAAGGC CATGAGTGGT 720
AGGTCATGGT CAAAGCATGT CCTCTTTCCT CAATAGCAGT GTTGGCCTAA ATTCATTCTC 780
CACTTCTTCG ACTCTCTTTC TCTTGGGTGA 810
|
